In a 57-year-old female with depression and attention-deficit/hyperactivity disorder, can I initiate bupropion sustained-release (SR) 100 mg daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Starting Bupropion SR 100 mg Daily in a 57-Year-Old Female with Depression and ADHD

No, you should not start bupropion SR at 100 mg daily—the standard FDA-approved dosing for bupropion SR requires starting at 150 mg once daily in the morning for days 1-3, then increasing to 150 mg twice daily (maximum 300 mg/day) if tolerated. 1

Correct Dosing Protocol

The FDA-approved titration schedule for bupropion SR is:

  • Days 1-3: 150 mg orally once daily in the morning
  • Day 4 onwards: 150 mg orally twice daily (if tolerated)
  • Maximum dose: 300 mg per day 2, 1

Starting at 100 mg daily is below the therapeutic threshold and not supported by evidence or FDA labeling. While some guidelines mention lower starting doses (37.5 mg for certain formulations), these refer to immediate-release preparations, not sustained-release 3.

Clinical Appropriateness for This Patient

Bupropion is an excellent choice for this patient with both depression and ADHD, as it addresses both conditions simultaneously:

For Depression

  • Bupropion is FDA-approved for major depressive disorder at 300 mg daily 4
  • It has demonstrated effectiveness for long-term treatment of recurrent major depression 4
  • It's a dopamine/norepinephrine reuptake inhibitor, offering a different mechanism than SSRIs 5

For ADHD

  • Low-quality evidence suggests bupropion decreases ADHD symptom severity (standardized mean difference -0.50) and increases clinical improvement rates (RR 1.50) 6
  • Bupropion is considered a first-line treatment for adults with comorbid mood disorders and ADHD 7
  • One randomized trial showed 64% response rate in ADHD adults treated with bupropion 8
  • The evidence for ADHD efficacy is mixed with small sample sizes and short-term assessments, but clinical experience supports its use 9, 6

Critical Safety Screening Required

Before prescribing, you must screen for absolute contraindications 1:

Absolute Contraindications

  • Seizure disorder or epilepsy history (bupropion lowers seizure threshold)
  • Current or past eating disorder (anorexia nervosa or bulimia)
  • Current use of MAO inhibitors (must have 2-week washout period)
  • Abrupt discontinuation of alcohol or benzodiazepines (increases seizure risk)
  • Allergy to bupropion

Important Cautions

  • Seizure risk factors: head injury, brain tumor, stroke history
  • Uncontrolled hypertension (monitor blood pressure regularly) 1
  • Bipolar disorder risk factors (screen for personal/family history—can precipitate mania) 1
  • Hepatic or renal impairment (dose adjustment needed)

Monitoring Plan

After starting at the correct dose (150 mg daily):

  1. Monitor for neuropsychiatric effects in first 2-4 weeks: worsening depression, suicidal ideation, agitation, unusual behavior 1
  2. Check blood pressure at baseline and periodically (hypertension reported in 2% of patients) 1
  3. Assess response at 4-8 weeks (full therapeutic trial requires this duration) 3
  4. Watch for seizures (risk increases with doses >300 mg/day) 1
  5. Evaluate for manic symptoms: increased energy, decreased sleep, racing thoughts, reckless behavior 1

Common Adverse Effects to Counsel About

The most common side effects (≥5% and twice placebo rate) include 1:

  • Dry mouth
  • Insomnia (give second dose before 3 PM to minimize) 3
  • Nausea
  • Tremor
  • Sweating
  • Agitation/anxiety

The tolerability profile is generally similar to placebo based on withdrawal rates due to adverse effects 6.

Special Considerations for This Patient

  • Age 57: No specific dose adjustment needed for age alone, but assess for comorbid conditions
  • Dual indication benefit: Treating both conditions with one medication improves adherence
  • If she smokes: Bupropion has the added benefit of supporting smoking cessation 4
  • If weight is a concern: Unlike many antidepressants, bupropion may promote modest weight loss 5

Bottom line: Start at 150 mg SR once daily (not 100 mg), ensure no contraindications exist, and titrate to 150 mg twice daily after 3 days if tolerated.

Related Questions

Can a 43-year-old woman with Asperger's syndrome, ADHD, panic disorder, and intrusive thoughts who is currently taking bupropion (Aplenzin) 174 mg take her available Concerta 27 mg (extended‑release methylphenidate) today in place of Jornay PM, and how should her ADHD medication regimen be adjusted to avoid crashes and side effects?
For a 57‑year‑old woman with major depressive disorder and attention‑deficit/hyperactivity disorder, is viloxazine a better treatment option than bupropion?
How effective is Wellbutrin (bupropion) for treating attention-deficit/hyperactivity disorder (ADHD)?
How does bupropion (Wellbutrin) improve mood and attention‑deficit/hyperactivity disorder symptoms, and why might a 300 mg dose cause worsening of mood and increased side effects in this patient?
Is Wellbutrin (bupropion) a suitable choice for a patient with depression and Attention Deficit Disorder (ADD) who exhibits hyperactivity?
In a patient with depression on fluoxetine 20 mg PO daily who reports modest improvement, decreased motivation, missed doses, disrupted sleep, minimal anxiety, and a recent episode of passive suicidal ideation, how should the fluoxetine be managed and what augmentation strategy should be considered?
What is the recommended evaluation and treatment plan for a patient being considered for lung transplantation?
What is the safest anxiolytic agent for use in a pregnant patient with anxiety?
What symptoms would a patient with cervical myelopathy due to anterior cord compression from C3‑C4 to C5‑C6 and severe right foraminal stenosis at C4‑C5 and C5‑C6 experience?
In a 14-year-old patient who has been off Vyvanse (lisdexamfetamine) for one year, is it appropriate to restart the medication without a new clinical evaluation?
What is the appropriate management for a patient who has been experiencing diarrhea for three days?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.